György M. Keserű

György M. Keserű obtained his Ph.D. at Budapest, Hungary and joined
Sanofi-Aventis CHINOIN heading a chemistry research lab. He moved to Gedeon
Richter in 1999 as the Head of Computer-aided Drug Discovery. He earned
D.Sc. from the Hungarian Academy of Science in 2003 and he was invited for a
research professorship at the Budapest University of Technology and
Economics. Since 2007 he was appointed as the Head of Discovery Chemistry at
Gedeon Richter. He contributed to the discovery of the antipsychotic
CariprazineR that is under NDA filing. From January 2013 he serves as the
general director of the Research Center for Natural Sciences at the
Hungarian Academy of Sciences. His research interests include medicinal
chemistry, drug design, and in silico ADME. He has published over 170 papers
and more than 10 books and book chapters.